Parathyroid hormone secretory responses to peroral phosphate and stimulability of serum levels of carboxyl-terminal flanking peptide (PDN-21) of the human calcitonin gene by calcium in normal subjects and osteoporotic patients.
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D002116:Calcitonin / Q000097:blood*; D002118:Calcium / Q000008:administration & dosage / Q000097:blood*; D000242:Cyclic AMP / Q000652:urine; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D010024:Osteoporosis / Q000097:blood / Q000503:physiopathology*; D010281:Parathyroid Hormone / Q000097:blood / Q000378:metabolism*; D010446:Peptide Fragments / Q000097:blood*; D010710:Phosphates / Q000008:administration & dosage / Q000494:pharmacology*; D012737:Sex Factors
D010281:Parathyroid Hormone; D010446:Peptide Fragments; D010710:Phosphates; C037553:katacalcin; D002116:Calcitonin; D000242:Cyclic AMP; D002118:Calcium